Aebersold received the Karger Medal from the Barnett Institute of Chemical & Biological Analysis in Boston, Masachusetts.
It recognizes an individual who has 'significantly contributed' to the development of new bioanalytical methods.
As part of the ceremony, Dr Aebersold presented two seminars, which highlighted his research in proteomics - the study of the entire set of proteins produced by healthy and diseased cells.
Both lectures included slides describing his use of Pressure BioSciences' novel, award winning, next-generation Barocycler 2320EXTREME for proteomic sample preparation in biomarker discovery and other research applications.
Quoting from the lectures, the firm said the doctor explained: "Not only do we need to consider the method of analyzing the proteome, we must also recognize that the method of sample preparation used for extraction and digestion of proteins is equally important to achieve a high degree of reproducibility of research results."
In 2015, Dr Aebersold and Dr Tiannan Guo collaborated with Pressure scientists and engineers to develop PCT-SWATH, a sample preparation and analysis method that combines the firm's sample preparation platform with SCIEX's SWATH-MS-based proteomics workflow.
PCT-SWATH is also notably employed by ProCan, a cancer research initiative at the Children's Medical Research Institute in Australia, which is also an NCI Cancer Moonshot collaborator.
Vice president of marketing and sales at Pressure BioSciences Dr Nate Lawrence, said: "We are delighted that Dr. Aebersold has again been recognized for his groundbreaking research in proteomics.
"We are honored to be both his colleague and collaborator in the development of instrumentation and methods essential in the preparation of samples for the discovery of protein biomarkers and other important applications.
"We look forward to working with Professor Aebersold and his team for years to come."
Shares in New York rose almost 6% to $6.99 each.